Amine Oxide Polymer Composition for Protein Stabilization and Blocking

The patent uses synthetic polymer compounds with specific structures (phosphorylcholine groups, amphoteric ion structures) that can be consistently manufactured without the variability inherent in biologically derived products. These synthetic blocking agents provide reliable, consistent performance across different batches, eliminating the need for lot-to-lot validation required with animal sera and biologically derived proteins.

The patent replaces expensive animal sera with synthetic polymer compounds that can be consistently manufactured. These polymers provide similar beneficial effects for cell proliferation and antibody production without the safety risks associated with animal-derived products, including prion diseases, viral contamination, and mycoplasma infection. The synthetic nature of the polymers eliminates the need for animal testing and regulatory approvals required for animal sera.

The patent employs composite polymer structures combining multiple functional groups (phosphorylcholine, amphoteric ions, and specific molecular weight ranges) to achieve both protein stability and high retention rates. The composite nature of these polymers allows them to interact with proteins through multiple mechanisms simultaneously, providing both stabilization and high retention performance that single-function polymers cannot achieve.

The patent uses synthetic polymer compounds with defined structures that can be manufactured through standardized chemical synthesis processes. These polymers eliminate the need for complex multi-step syntheses and refinements required for copolymers with phosphorylcholine groups, significantly improving productivity while maintaining protein stabilization performance.